This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Vildagliptin
From Proteopedia
(Difference between revisions)
(New page: <applet load="" size="480" color="" frame="true" spin="on" Scene ="" align="right" caption="Vildagliptin, better known as ____, (___)"/> ===Better Known as: === * Marketed By: * Maj...) |
|||
| Line 1: | Line 1: | ||
| - | <applet load="" size="480" color="" frame="true" spin="on" Scene ="" align="right" caption="Vildagliptin, better known as | + | <applet load="" size="480" color="" frame="true" spin="on" Scene ="" align="right" caption="Vildagliptin, better known as Galvus, ([[___]])"/> |
| - | ===Better Known as: === | + | ===Better Known as: Galvus=== |
* Marketed By: | * Marketed By: | ||
* Major Indication: | * Major Indication: | ||
Revision as of 09:33, 13 December 2010
|
Better Known as: Galvus
- Marketed By:
- Major Indication:
- Drug Class:
- Date of FDA Approval (Patent Expiration):
- 2009 Sales:
- Importance:
- See Pharmaceutical Drugs for more information about other drugs and diseases.
Mechanism of Action
Pharmacokinetics
For Pharmacokinetic Data References, see: References |
|||||||||||||||||||||||||||||||||||||||||||||||||||||
References
